Percutaneous double-valve balloon valvotomy for multivalve stenosis: Immediate results and intermediate-term follow-up

• Published in: The American heart journal Vol. 133; no. 1; pp. 64 - 70
• Main Authors: Sharma, Satyavan, Loya, Yunus Shafi, Desai, Dhruman Mohanbhai, Pinto, Robin Joseph
• Format: Journal Article
• Language: English
• Published: New York, NY Mosby, Inc 1997; Elsevier
• Subjects: Adolescent; Adult; Aortic Valve Stenosis - complications; Aortic Valve Stenosis - diagnostic imaging; Aortic Valve Stenosis - physiopathology; Aortic Valve Stenosis - therapy; Biological and medical sciences; Cardiology. Vascular system; Catheterization - methods; Echocardiography, Doppler; Endocardial and cardiac valvular diseases; Female; Follow-Up Studies; Heart; Hemodynamics; Humans; Male; Medical sciences; Mitral Valve Stenosis - complications; Mitral Valve Stenosis - diagnostic imaging; Mitral Valve Stenosis - physiopathology; Mitral Valve Stenosis - therapy; Treatment Outcome; Tricuspid Valve Stenosis - complications; Tricuspid Valve Stenosis - diagnostic imaging; Tricuspid Valve Stenosis - physiopathology; Tricuspid Valve Stenosis - therapy; Human; Mitral valve; Treatment efficiency; Instrumentation therapy; Cuffed tube; Cardiovascular disease; Narrowing; Instrumental dilatation; Percutaneous route; Treatment; Cardiac valvular disease; Hemodynamics; Technique; Tricuspid valve; Aortic valve
• ISSN: 0002-8703; 1097-6744
• DOI: 10.1016/S0002-8703(97)70249-7

Ten patients each with combined mitral and tricuspid stenosis (group 1) and with combined mitral and aortic stenosis (group 2) underwent double-valve balloon valvotomy as a single staged procedure. The aortic valve was dilated by the Mansfield balloon technique, whereas the mitral and tricuspid valves were dilated with either the Mansfield or Inoue balloon. The mitral valve area increased from 0.78 ± 0.21 cm
2 to 2.05 ± 0.56 cm
2 (
p < 0.0005) in group 1 and from 0.75 ± 0.20 cm
2 to 2.1 ± 0.59 cm
2 (
p < 0.05) in group 2. The tricuspid valve area increased from 1.11 ± 0.41 cm
2 to 2.52 ± 0.69 cm
2 (
p < 0.0005). In group 2, the transaortic gradient decreased from 93.56 ± 17.7 mm Hg to 28.56 ± 7.8 mm Hg (
p < 0.0005) and the valve area increased from 0.37 ± 0.05 cm
2 to 1.03 ± 0.25 cm
2 (
p < 0.005). The excellent symptomatic and hemodynamic results were sustained at 30.3 ± 9.8 months of follow-up in group 1 and at 23.5 ± 9.1 months in group 2. Double-valve balloon valvotomy is feasible and safe and provides excellent immediate and intermediate-term follow-up results in selected patients with multivalve disease. A longer follow-up in a larger number of cases is needed to define further the role of this therapy. (Am Heart J 1997;133:64-70.)